Diagnostic Approaches for H. pylori Infection

Diagnostic Test Characteristics

The American Gastroenterological Association recommends the urea breath test (UBT) as the gold standard for diagnosing H. pylori infection, with a sensitivity of 88-95% and specificity of 95-100% 1, 2
The stool antigen test (SAT) has equivalent accuracy to UBT when a validated laboratory-based monoclonal test is used, with sensitivity and specificity exceeding 90% 1, 4
The European Helicobacter Study Group recommends using laboratory-based monoclonal SATs for both initial and post-treatment diagnosis, as they have high accuracy when validated tests are employed 1, 4

The American College of Gastroenterology suggests choosing between UBT and laboratory-based monoclonal SAT based on local availability, cost, and patient preference for initial diagnosis in asymptomatic patients 2
For post-treatment confirmation, either UBT or laboratory-based monoclonal SAT should be used at least 4 weeks after treatment completion, as recommended by the Infectious Diseases Society of America 3
When UBT shows an unexpected positive result, especially in patients with known achlorhydria or atrophy, confirmation with SAT is recommended before initiating additional therapy, according to the American Gastroenterological Association 4, 6

The European Helicobacter Study Group recommends discontinuing antibiotics and bismuth for at least 4 weeks before testing, as well as discontinuing PPIs for at least 7-14 days (minimum 2 weeks preferred) to avoid false negative results 7, 2, 3
Ensuring a 6-hour fasting period before testing is also recommended, as stated by the American College of Gastroenterology 2

The American Gastroenterological Association recommends excluding serology for active infection diagnosis, as it cannot distinguish current infection from past exposure, and instead using either UBT or laboratory-based monoclonal SAT for initial diagnosis 1, 2
For post-treatment confirmation, either UBT or laboratory-based monoclonal SAT should be used at least 4 weeks after treatment completion, as recommended by the Infectious Diseases Society of America 3